Cancellation & Refund Policy

You may cancel your membership or certification at any time by notifying us on admin@clinicalresearchsociety.org. Any membership or certification fee paid is non-refundable and non-transferable under any circumstances whatsoever.

 

 

 

Privacy Policy

Privacy Policy

Clinical Research Society operates the https://www.clinicalresearchsociety.org website, which provides the SERVICE.

This page is used to inform website visitors regarding our policies with the collection, use, and disclosure of Personal Information if anyone decided to use our Service.

If you choose to use our Service, then you agree to the collection and use of information in relation with this policy. The Personal Information that we collect are used for providing…

Disclaimer Policy

Disclaimer for Clinical Research Society

If you require any more information or have any questions about our site’s disclaimer, please feel free to contact us by email at admin@clinicalresearchsociety.org. Disclaimers for https://www.clinicalresearchsociety.org

All the information on this website is published in good faith and for general information purpose only. https://www.clinicalresearchsociety.org does not make any warranties about the completeness, reliability and accuracy of this information. Any action you take upon the information you…

New Soft Robot can Help you Beat your Heart Normally

A team of investigators has developed a robotic sleeve able of artificially resembling the muscles of the heart. This new technology could be a life saver for people with heart failure waiting for transplant.

Heart failure takes place when either of the heart’s ventricles can no more accomplish their duty of…

More than 30% of Asthma Patients Misdiagnosed

Asthma impacts 300 millions of individuals globally. However, new Canadian research indicates that a considerable number of asthma cases may be wrongly diagnosed.

Asthma is a chronic illness impacting the bronchial tubes, which generally allow air to come in and out of the lungs.

This new study, presented in JAMA, indicates that the situation may be over-diagnosed.

Investigators led by Dr. Shawn Aaron, analyzed…

Repo-Man Protein Might Helpful in Treating Aggressive Cancers

A protein that regulates cell division also has an essential role in switching genes on / off, researchers have identified, in a discovery which could change cancer treatment.

The protein phosphatase, Repo-Man is one of a clutch of essential proteins in cell division, an important process that goes into overdrive in cancer.

Now investigators at Brunel…

Small Increase in Zinc Consumption Can Stop DNA Damage

Zinc is an important mineral that facilitates human development and growth, along with assisting to keep the body’s immune system healthy. New study advises that even a small raise in daily zinc consumption can assist the body to safeguard its DNA.

Zinc is important for human development while in pregnancy, childhood, and adolescence; it is involved in many elements of cellular metabolism…

Scientists Grow Stomach in Laboratory

Researchers from Cincinnati Children’s Hospital Medical Center have developed a way in which cells from the stomach’s corpus/fundus region can be developed in the laboratory. These small organs could help research into common gastrointestinal problems and enhance drug research.

Stomach illnesses…

Is It Good To Drink Plenty Of Water When You Are Ill?

Physicians have generally advised individuals to drink a lot of water if sick. A new case study reports the dangers of consuming too much water and shows the need for more study to support this standard advice.

For years, the major medical advice in case of flu or respiratory infections has been to consume a lot of fluids.

Theoretically, this is regarded good…

Eli Lilly’s Lartruvo Gets FDA Accelerated Approval to Treat Soft Tissue Sarcoma

U.S. regulatory authority Food and Drug Administration on 19th October 2016, granted accelerated approval to Eli Lilly’s Lartruvo, a drug that treats advanced soft tissue sarcoma (STS) in adults.

Lartruvo, is approved for use with the FDA  approved chemotherapy drug doxorubicin in STS patients who can’t be cured with radiation or surgery or who have a type of STS for which a…